Log In
Print
BCIQ
Print
Print this Print this
 

Squalamine eye drops (OHR-102)

  Manage Alerts
Collapse Summary General Information
Company Ohr Pharmaceutical Inc.
DescriptionTopical eye drop formulation of the synthetic small molecule anti-angiogenic aminosterol
Molecular Target Calmodulin
Mechanism of ActionAngiogenesis inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today